Business
Johnson & Johnson’s prescription for growth on December 6, 2023 at 7:16 pm Entrepreneur: Latest Articles
J&J projects 5-6% revenue growth in 2024, fueled by strong core businesses, acquisitions, and a robust pipeline targeting $57 billion in drug sales by 2025.
Finance J&J projects 5-6% revenue growth in 2024, fueled by strong core businesses, acquisitions, and a robust pipeline targeting $57 billion in drug sales by 2025.